Biosimilar Clinical Development: Scientific Considerations and New Methodologies (ePub)
(Sprache: Englisch)
Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written...
sofort als Download lieferbar
eBook (ePub)
63.30 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Biosimilar Clinical Development: Scientific Considerations and New Methodologies (ePub)“
Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
Autoren-Porträt
Dr. Kerry B. Barker is the Vice-President and Head of Early Oncology Research Statistics at Pfizer, Dr. Sandeep Menon is the Vice-President and Head of Biostatistics Research and Consulting Center at Pfizer , Dr. Ralph D'Agostino is a professor of Mathematics and Statistics at Boston University, Dr. Siyan Xu is a senior principal biostatistician at Novartis and Dr.Bo Jin is the Director of Biostatistics in Early Oncology Research at Pfizer. All have been involved with biosimilars clinical development across all regions of the world.
Bibliographische Angaben
- 2016, 268 Seiten, Englisch
- Herausgegeben: Kerry B. Barker, Sandeep M. Menon, Ralph B. D'Agostino Sr., Siyan Xu, Bo Jin
- Verlag: Taylor & Francis
- ISBN-10: 1315355906
- ISBN-13: 9781315355900
- Erscheinungsdatum: 25.11.2016
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: ePub
- Größe: 3.98 MB
- Mit Kopierschutz
- Vorlesefunktion
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "Biosimilar Clinical Development: Scientific Considerations and New Methodologies"
Schreiben Sie einen Kommentar zu "Biosimilar Clinical Development: Scientific Considerations and New Methodologies".
Kommentar verfassen